Ryan LM - Search Results

1

PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma.

Witte RS, Ryan LM, Schutt AJ, Carbone PP, Engstrom PF. Witte RS, et al. Among authors: ryan lm. Invest New Drugs. 1998-1999;16(4):315-8. doi: 10.1023/a:1006292218890. Invest New Drugs. 1998. PMID: 10426663

2

Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus.

Engstrom PF, Ryan LM, Falkson G, Haller DG. Engstrom PF, et al. Among authors: ryan lm. Am J Clin Oncol. 1991 Feb;14(1):33-5. doi: 10.1097/00000421-199102000-00007. Am J Clin Oncol. 1991. PMID: 1987735 Clinical Trial.

3

A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study.

Falkson G, Ryan LM, Johnson LA, Simson IW, Coetzer BJ, Carbone PP, Creech RH, Schutt AJ. Falkson G, et al. Among authors: ryan lm. Cancer. 1987 Nov 1;60(9):2141-5. doi: 10.1002/1097-0142(19871101)60:9<2141::aid-cncr2820600903>3.0.co;2-4. Cancer. 1987. PMID: 2830952 Clinical Trial.

4

Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.

Novik Y, Ryan LM, Haller DG, Asbury R, Dutcher JP, Schutt A. Novik Y, et al. Among authors: ryan lm. Med Oncol. 1999 Dec;16(4):261-6. doi: 10.1007/BF02785872. Med Oncol. 1999. PMID: 10618689 Clinical Trial.

5

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.

Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J, Sischy B. Smith TJ, et al. Among authors: ryan lm. Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):269-76. doi: 10.1016/s0360-3016(98)00232-6. Int J Radiat Oncol Biol Phys. 1998. PMID: 9788404 Free article. Clinical Trial.

6

Prognostic factors for survival in hepatocellular carcinoma.

Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Falkson G, et al. Among authors: ryan lm. Cancer Res. 1988 Dec 15;48(24 Pt 1):7314-8. Cancer Res. 1988. PMID: 2847868 Review.

7

Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.

Hansen RM, Ryan L, Anderson T, Krzywda B, Quebbeman E, Benson A 3rd, Haller DG, Tormey DC. Hansen RM, et al. J Natl Cancer Inst. 1996 May 15;88(10):668-74. doi: 10.1093/jnci/88.10.668. J Natl Cancer Inst. 1996. PMID: 8627643 Clinical Trial.

8

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR. Edmonson JH, et al. Among authors: ryan lm. J Clin Oncol. 1993 Jul;11(7):1269-75. doi: 10.1200/JCO.1993.11.7.1269. J Clin Oncol. 1993. PMID: 8315424 Clinical Trial.

9

Phase II trial of gemcitabine in patients with advanced sarcomas (E1797): a trial of the Eastern Cooperative Oncology Group.

Okuno S, Ryan LM, Edmonson JH, Priebat DA, Blum RH. Okuno S, et al. Among authors: ryan lm. Cancer. 2003 Apr 15;97(8):1969-73. doi: 10.1002/cncr.11290. Cancer. 2003. PMID: 12673725 Free article. Clinical Trial.

10

Mesna, doxorubicin, ifosfamide, dacarbazine (MAID) regimen for adults with advanced sarcoma.

Elias A, Ryan L, Aisner J, Antman KH. Elias A, et al. Semin Oncol. 1990 Apr;17(2 Suppl 4):41-9. Semin Oncol. 1990. PMID: 2110385

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page